NVO logo

Novo Nordisk A/S (NVO) Current Assets

Annual Current Assets

$22.45 B
+$1.71 B+8.27%

December 31, 2024


Summary


Performance

NVO Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVObalance sheetmetrics:

Quarterly Current Assets

$22.45 B
-$6.78 B-23.21%

December 31, 2024


Summary


Performance

NVO Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVObalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

NVO Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.3%-11.9%
3 y3 years+72.3%+72.3%
5 y5 years+139.7%+139.7%

NVO Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+72.3%-23.2%+72.9%
5 y5-yearat high+139.7%-23.2%+140.5%
alltimeall timeat high+5760.6%-23.2%+5760.6%

Novo Nordisk A/S Current Assets History

DateAnnualQuarterly
Dec 2024
$42.54 B(+63.9%)
$22.45 B(-23.2%)
Sep 2024
-
$29.23 B(+14.7%)
Jun 2024
-
$25.48 B(+51.3%)
Mar 2024
-
$16.84 B(-18.8%)
Dec 2023
$25.96 B(+35.5%)
$20.73 B(+2.9%)
Sep 2023
-
$20.14 B(+0.3%)
Jun 2023
-
$20.07 B(+20.3%)
Mar 2023
-
$16.68 B(+7.1%)
Dec 2022
$19.15 B(+15.5%)
$15.57 B(-1.4%)
Sep 2022
-
$15.79 B(+9.2%)
Jun 2022
-
$14.46 B(+11.3%)
Mar 2022
-
$12.99 B(-0.3%)
Dec 2021
$16.58 B(+26.8%)
$13.03 B(-8.4%)
Sep 2021
-
$14.23 B(+15.3%)
Jun 2021
-
$12.35 B(+27.6%)
Mar 2021
-
$9.68 B(-11.0%)
Dec 2020
$13.08 B(+38.1%)
$10.88 B(-6.4%)
Sep 2020
-
$11.62 B(+4.6%)
Jun 2020
-
$11.10 B(+18.9%)
Mar 2020
-
$9.33 B(-0.3%)
Dec 2019
$9.47 B(+19.5%)
$9.36 B(+0.8%)
Sep 2019
-
$9.29 B(+3.9%)
Jun 2019
-
$8.95 B(+12.9%)
Mar 2019
-
$7.92 B(-12.4%)
Dec 2018
$7.92 B(+16.3%)
$9.05 B(+7.4%)
Sep 2018
-
$8.42 B(-5.6%)
Jun 2018
-
$8.92 B(+8.1%)
Mar 2018
-
$8.25 B(-14.8%)
Dec 2017
$6.81 B(+26.8%)
$9.68 B(+7.1%)
Sep 2017
-
$9.04 B(-0.4%)
Jun 2017
-
$9.07 B(+13.5%)
Mar 2017
-
$7.99 B(-5.9%)
Dec 2016
$5.37 B(+0.0%)
$8.50 B(+9.5%)
Sep 2016
-
$7.76 B(-1.4%)
Jun 2016
-
$7.87 B(+11.6%)
Mar 2016
-
$7.05 B(-12.7%)
Dec 2015
$5.37 B(+6.9%)
$8.08 B(+4.0%)
Sep 2015
-
$7.77 B(+9.1%)
Jun 2015
-
$7.12 B(+12.9%)
Mar 2015
-
$6.30 B(-16.6%)
Dec 2014
$5.02 B(-4.0%)
$7.56 B(+7.7%)
Sep 2014
-
$7.02 B(+12.1%)
Jun 2014
-
$6.26 B(-1.5%)
Mar 2014
-
$6.35 B(-18.4%)
Dec 2013
$5.23 B(+15.8%)
$7.78 B(+5.2%)
Sep 2013
-
$7.40 B(+16.0%)
Jun 2013
-
$6.38 B(+3.7%)
Mar 2013
-
$6.15 B(-13.6%)
Dec 2012
$4.52 B(+3.3%)
$7.12 B(+0.5%)
Sep 2012
-
$7.08 B(+17.8%)
Jun 2012
-
$6.01 B(-7.6%)
Mar 2012
-
$6.51 B(-5.7%)
DateAnnualQuarterly
Dec 2011
$4.38 B(+1.7%)
$6.90 B(-2.6%)
Sep 2011
-
$7.08 B(-3.7%)
Jun 2011
-
$7.35 B(+9.5%)
Mar 2011
-
$6.71 B(+0.9%)
Dec 2010
$4.30 B(+1.3%)
$6.65 B(+7.3%)
Sep 2010
-
$6.20 B(+11.8%)
Jun 2010
-
$5.54 B(-2.6%)
Mar 2010
-
$5.69 B(-9.4%)
Dec 2009
$4.25 B(+4.8%)
$6.28 B(+3.0%)
Sep 2009
-
$6.10 B(+8.9%)
Jun 2009
-
$5.60 B(+10.0%)
Mar 2009
-
$5.10 B(-6.8%)
Dec 2008
$4.05 B(-11.7%)
$5.47 B(+6.7%)
Sep 2008
-
$5.12 B(-7.5%)
Jun 2008
-
$5.54 B(+6.0%)
Mar 2008
-
$5.22 B(+9.8%)
Dec 2007
$4.59 B(+8.7%)
$4.76 B(+6.9%)
Sep 2007
-
$4.45 B(+6.7%)
Jun 2007
-
$4.17 B(+11.2%)
Mar 2007
-
$3.75 B(+1.7%)
Dec 2006
$4.22 B(+18.9%)
$3.69 B(+5.6%)
Sep 2006
-
$3.49 B(+0.3%)
Jun 2006
-
$3.48 B(+13.6%)
Mar 2006
-
$3.06 B(-1.2%)
Dec 2005
$3.55 B(-1.7%)
$3.10 B(+5.9%)
Sep 2005
-
$2.93 B(+7.8%)
Jun 2005
-
$2.71 B(-4.6%)
Mar 2005
-
$2.84 B(-12.6%)
Dec 2004
$3.61 B(+17.3%)
$3.25 B(+17.8%)
Sep 2004
-
$2.76 B(+8.3%)
Jun 2004
-
$2.55 B(+1.5%)
Mar 2004
-
$2.51 B(-8.9%)
Dec 2003
$3.08 B(+23.1%)
$2.76 B(+42.0%)
Dec 2002
$2.50 B(+40.5%)
$1.94 B(+18.5%)
Dec 2001
$1.78 B(+18.2%)
$1.64 B(+4.9%)
Dec 2000
$1.50 B(+5.3%)
$1.56 B(-7.5%)
Dec 1999
$1.43 B(-36.1%)
$1.69 B(-17.4%)
Dec 1998
$2.24 B(+18.7%)
$2.05 B(+8.6%)
Dec 1997
$1.88 B(-0.9%)
$1.88 B(+1.9%)
Dec 1996
$1.90 B(+0.4%)
$1.85 B(+6.5%)
Dec 1995
$1.89 B(+45.3%)
$1.74 B(-20.0%)
Dec 1994
$1.30 B(-12.1%)
$2.17 B(+59.7%)
Dec 1993
$1.48 B(+49.7%)
$1.36 B(-19.6%)
Dec 1992
$990.68 M(-13.7%)
$1.69 B(+17.8%)
Dec 1991
$1.15 B(+13.2%)
$1.44 B(+25.0%)
Dec 1990
$1.01 B(+27.3%)
$1.15 B(+18.8%)
Dec 1989
$796.27 M(+26.4%)
$966.37 M(+36.0%)
Dec 1988
$629.89 M(-5.7%)
$710.80 M(+3.5%)
Dec 1987
$667.63 M(+29.1%)
$687.01 M(+16.1%)
Dec 1986
$517.16 M(+51.0%)
$591.69 M(+23.7%)
Dec 1985
$342.58 M(+45.0%)
$478.19 M(+24.8%)
Dec 1984
$236.30 M
$383.03 M

FAQ

  • What is Novo Nordisk A/S annual total current assets?
  • What is the all time high annual current assets for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual current assets year-on-year change?
  • What is Novo Nordisk A/S quarterly total current assets?
  • What is the all time high quarterly current assets for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly current assets year-on-year change?

What is Novo Nordisk A/S annual total current assets?

The current annual current assets of NVO is $22.45 B

What is the all time high annual current assets for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual total current assets is $22.45 B

What is Novo Nordisk A/S annual current assets year-on-year change?

Over the past year, NVO annual total current assets has changed by +$1.71 B (+8.27%)

What is Novo Nordisk A/S quarterly total current assets?

The current quarterly current assets of NVO is $22.45 B

What is the all time high quarterly current assets for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly total current assets is $29.23 B

What is Novo Nordisk A/S quarterly current assets year-on-year change?

Over the past year, NVO quarterly total current assets has changed by -$3.03 B (-11.90%)